Dinesh Dua, CEO & Director of Nectar Life Sciences, said the company has registered a growth of 8 per cent despite headwinds. He expects the company's earnings to improve in September quarter. He said the firm has eight ANDAs lined up for Europe. The company plans to expand in Japan and Korea in the coming quarters and will start expanding in US markets Soon. Here's more.